Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making.

@article{Harris2009DiseaseBI,
  title={Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making.},
  author={Violaine K Harris and Saud Ahmed Sadiq},
  journal={Molecular diagnosis & therapy},
  year={2009},
  volume={13 4},
  pages={
          225-44
        }
}
Multiple sclerosis (MS) is an autoimmune disorder of the brain and spinal cord that predominantly affects white matter. MS has a variable clinical presentation and has no 'diagnostic' laboratory test; this often results in delays to definite diagnosis. In confronting the disease, early diagnosis and appropriate, timely therapeutic intervention are critical factors in ensuring favorable long-term outcomes. The availability of reliable biomarkers could radically alter our management of MS at… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 50 CITATIONS

Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status

  • Molecular Diagnosis & Therapy
  • 2014
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Biomarkers of multiple sclerosis: current findings

  • Degenerative neurological and neuromuscular disease
  • 2017
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Recommendations for useful serum testing with suspected multiple sclerosis.

  • Revue neurologique
  • 2013
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2010
2018

CITATION STATISTICS

  • 5 Highly Influenced Citations

  • Averaged 4 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 203 REFERENCES

Multiple sclerosis

SA Sadiq
  • Roland LP, editor. Merritt’s neurology. 11th ed. Philadelphia (PA): Lippincott,
  • 2005
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Cerebrospinal fluid myelin basic protein and multiple sclerosis.

  • Advances in experimental medicine and biology
  • 1978
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial Biomarkers for Multiple Sclerosis 239 a 2009 Adis Data Information BV

JC Corvol, D Pelletier, RG Henry
  • All rights reserved. Mol Diagn Ther
  • 2009
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…